Vertex Pharmaceuticals Retained Earnings (Accumulated Deficit) 2010-2025 | VRTX
Vertex Pharmaceuticals retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $10.253B, a 8.8% decline year-over-year.
- Vertex Pharmaceuticals retained earnings (accumulated deficit) for 2024 were $9.607B, a 5.28% decline from 2023.
- Vertex Pharmaceuticals retained earnings (accumulated deficit) for 2023 were $10.142B, a 55.49% increase from 2022.
- Vertex Pharmaceuticals retained earnings (accumulated deficit) for 2022 were $6.523B, a 103.79% increase from 2021.